IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

New Leaf Venture Partners, L.L.C.

Q3 2024 Holdings

Filed 2024-11-13 | 10 holdings | $97.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Edgewise Therapeutics Inc(EWTX)COM28036F105$41.5M1,553,66142.6%
Arvinas Inc(ARVN)COM04335A105$35.3M1,434,72136.3%
Crinetics Pharmaceuticals Inc(CRNX)COM22663K107$7.2M141,0007.4%
Rallybio CorporationCOM75120L100$3.9M3,301,6034.0%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$2.8M150,7062.9%
Cogent Biosciences Inc.(COGT)COM19240Q201$2.7M250,7652.8%
Passage BIOCOM702712100$1.7M2,497,9221.8%
Alector Inc(ALEC)COM014442107$1.6M339,5691.6%
Iterum Therapeutics PLCSHSG6333L200$376.1K345,0200.4%
X4 Pharmaceuticals Inc(ASNSUSD)COM98420X103$224.1K335,0000.2%